HUE039458T2 - Röntgen kontrasztanyagok tisztítása - Google Patents

Röntgen kontrasztanyagok tisztítása

Info

Publication number
HUE039458T2
HUE039458T2 HUE13864437A HUE13864437A HUE039458T2 HU E039458 T2 HUE039458 T2 HU E039458T2 HU E13864437 A HUE13864437 A HU E13864437A HU E13864437 A HUE13864437 A HU E13864437A HU E039458 T2 HUE039458 T2 HU E039458T2
Authority
HU
Hungary
Prior art keywords
purification
contrast agents
ray contrast
ray
agents
Prior art date
Application number
HUE13864437A
Other languages
English (en)
Inventor
Jan Cervenka
Mikkel Thaning
Andreas Olsson
Christian Glogard
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of HUE039458T2 publication Critical patent/HUE039458T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
HUE13864437A 2012-12-19 2013-11-19 Röntgen kontrasztanyagok tisztítása HUE039458T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12198020 2012-12-19

Publications (1)

Publication Number Publication Date
HUE039458T2 true HUE039458T2 (hu) 2019-01-28

Family

ID=47458704

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13864437A HUE039458T2 (hu) 2012-12-19 2013-11-19 Röntgen kontrasztanyagok tisztítása

Country Status (15)

Country Link
US (1) US9938233B2 (hu)
EP (1) EP2935204B1 (hu)
JP (2) JP6342421B2 (hu)
KR (1) KR102180250B1 (hu)
CN (1) CN104854080B (hu)
AU (1) AU2013364113B2 (hu)
CA (1) CA2890449C (hu)
ES (1) ES2690128T3 (hu)
HU (1) HUE039458T2 (hu)
IN (1) IN2015DN03980A (hu)
NZ (1) NZ708503A (hu)
PL (1) PL2935204T3 (hu)
RU (1) RU2662941C2 (hu)
SG (1) SG11201504201RA (hu)
WO (1) WO2014099214A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201504201RA (en) 2012-12-19 2015-07-30 Ge Healthcare As Purification of x-ray contrast agents
KR101699539B1 (ko) * 2015-12-30 2017-02-13 (주)솔레이어 나노 여과 모듈 및 이를 이용한 농축 방법
CN113121377A (zh) * 2019-12-31 2021-07-16 江苏汉邦科技有限公司 碘克沙醇的纯化方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248741B (it) * 1991-02-26 1995-01-26 Bracco Spa Processo di concentrazione e di purificazione di composti organici
US5447635A (en) * 1991-02-26 1995-09-05 Bracco International B.V. Process of concentration and purification of organic compounds
US5221485A (en) * 1991-12-03 1993-06-22 Mallinckrodt Medical, Inc. Purification of X-ray contrast agent, magnetic resonance imaging agent, or radiopharmaceuticals using reverse osmosis
EP0612692B1 (en) 1993-02-26 1999-01-20 Createrra Inc. Method for production of water purifying substances
IL110391A (en) * 1993-07-30 1998-12-06 Zambon Spa Process for the formation of infamidol
IT1282674B1 (it) * 1996-02-23 1998-03-31 Bracco Spa Processo per la purificazione di agenti contrastografici opacizzanti
US5811581A (en) 1994-08-04 1998-09-22 Dibra S.P.A. Process for the purification of opacifying contrast agents
US6425885B1 (en) 1999-12-20 2002-07-30 Ultradent Products, Inc. Hydraulic syringe
NO20043305D0 (no) 2004-08-09 2004-08-09 Amersham Health As Preparation of lodixanol
NO20053676D0 (no) 2005-07-29 2005-07-29 Amersham Health As Crystallisation Process
NO20055643D0 (no) * 2005-11-29 2005-11-29 Amersham Health As Preparation of lodixanol
US8920780B2 (en) * 2007-07-12 2014-12-30 Ge Healthcare As Contrast agents
WO2009091758A1 (en) * 2008-01-14 2009-07-23 Mallinckrodt Inc. Process for the preparation of iosimenol
US20110021823A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As Processing crude iodixanol mixture by nanofiltration
BR112012012497B1 (pt) * 2009-11-26 2021-09-08 Hovione China Holding Limited Método para preparar iodixanol
EP2655318B1 (en) 2010-12-21 2018-06-20 GE Healthcare AS Desalination of a composition comprising a contrast agent
SG11201504201RA (en) 2012-12-19 2015-07-30 Ge Healthcare As Purification of x-ray contrast agents

Also Published As

Publication number Publication date
CN104854080A (zh) 2015-08-19
CA2890449C (en) 2020-12-29
EP2935204A1 (en) 2015-10-28
KR20150094639A (ko) 2015-08-19
AU2013364113B2 (en) 2018-01-18
EP2935204A4 (en) 2016-08-17
RU2662941C2 (ru) 2018-07-31
PL2935204T3 (pl) 2018-12-31
JP2018115193A (ja) 2018-07-26
AU2013364113A1 (en) 2015-05-28
WO2014099214A1 (en) 2014-06-26
NZ708503A (en) 2019-08-30
IN2015DN03980A (hu) 2015-10-02
EP2935204B1 (en) 2018-09-05
CA2890449A1 (en) 2014-06-26
US20160304440A1 (en) 2016-10-20
CN104854080B (zh) 2018-07-03
RU2015121502A (ru) 2017-01-26
KR102180250B1 (ko) 2020-11-18
JP2016503054A (ja) 2016-02-01
SG11201504201RA (en) 2015-07-30
ES2690128T3 (es) 2018-11-19
JP6342421B2 (ja) 2018-06-13
US9938233B2 (en) 2018-04-10

Similar Documents

Publication Publication Date Title
IL287057A (en) Purified iduronate-2-sulfatase
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2826473A4 (en) NEW USE OF PATCHOULOL
ZA201406082B (en) Use of ccr3-inhibitors
SG10201510800PA (en) Purification of flaviviruses
HK1210718A1 (en) Antitrichophytosis solution for external use
EP2881113A4 (en) NEW APPLICATION OF POGOSTONE
PT2917174T (pt) Preparação de intermediários de agentes de contraste de raios-x
IL232239A0 (en) Medical use
ZA201308101B (en) Diagnostic use of prosomatostatin
EP2892529A4 (en) USES OF (-) - PERHEXILINE
GB201205189D0 (en) Novel medical use
SG11201504201RA (en) Purification of x-ray contrast agents
GB201215502D0 (en) Medical use
HK1210421A1 (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3-
EP2908871A4 (en) ABSTRACT PROCESSING TECHNIQUES
IL236873A0 (en) therapeutic compounds
GB201218263D0 (en) Treatment of autism
GB201215621D0 (en) Medical solution
GB201221118D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201204645D0 (en) Treatment of disease
GB201212604D0 (en) New treatment
GB201206324D0 (en) Methods of treatment